Scarica l'app Stockscreener
155.61
0.93%
1.43
Dopo l'orario di chiusura:
155.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$154.18
Aprire:
$153.74
Volume 24 ore:
1.12M
Relative Volume:
0.56
Capitalizzazione di mercato:
$17.36B
Reddito:
$2.90B
Utile/perdita netta:
$239.11M
Rapporto P/E:
73.76
EPS:
2.1097
Flusso di cassa netto:
$492.62M
1 W Prestazione:
-1.11%
1M Prestazione:
+25.18%
6M Prestazione:
+73.30%
1 anno Prestazione:
+76.25%
Intervallo 1D:
$153.46
$156.33
Intervallo di 1 settimana:
$146.70
$156.33
Portata 52W:
$81.22
$166.25
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
155.61 | 17.36B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
662.24 | 244.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.20 | 155.50B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
397.77 | 57.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
171.33 | 48.30B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.21 | 43.16B | 16.63B | 1.39B | 2.12B | 8.0674 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-06 | Iniziato | William Blair | Outperform |
| 2026-09-09 | Ripresa | UBS | Neutral |
| 2026-09-01 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2026-06-26 | Ripresa | Bernstein | Mkt Perform |
| 2026-06-02 | Ripresa | Wolfe Research | Peer Perform |
| 2026-04-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-12-09 | Iniziato | Goldman | Neutral |
| 2025-10-16 | Iniziato | Guggenheim | Neutral |
| 2025-05-01 | Aggiornamento | UBS | Neutral → Buy |
| 2025-01-10 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-08 | Iniziato | Leerink Partners | Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
Revvity, Inc. Stock 12‑Month Price Target Raised to $142.93, Implies 6% Downside - TradingView
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo! Finance Canada
What Does Revvity (NYSE:RVTY) New Assay Add to NYSE Composite? - Kalkine Media
Baird Adjusts Price Target on Revvity to $164 From $144 - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
T. Rowe Price reports sole voting power over 12.9M shares in Revvity (RVTY). - Stock Titan
Revvity Inc (RVTY) Stock Earnings Transcripts - GuruFocus
Revvity Inc at Barclays Global Healthcare Conference Transcript - GuruFocus
Revvity Earnings Preview: What to Expect - Barchart.com
What's Going On With Revvity Stock Tuesday?Revvity (NYSE:RVTY) - Benzinga
Barclays Adjusts Price Target on Revvity to $160 From $115, Maintains Equalweight Rating - Yahoo Finance
Revvity to Host Investor Day - Business Wire
Revvity to Host Investor Day - Yahoo Finance
William Blair Initiates Revvity at Outperform - Yahoo Finance
Revvity Inc (RVTY) Stock Up 3.9% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Revvity Inc (MIL:1RVTY) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Revvity Inc Stock Operating Data - GuruFocus
Who's Buying or Selling Revvity Inc (MIL:1RVTY) Stock Today? - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity Inc (MIL:1RVTY) Stock Price, Trades & News - GuruFocus
Revvity Inc (RVTY) VP and Chief Accounting Officer Anita Gonzales Sells 84 Shares - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
A planned 84-share sale leaves Revvity (RVTY) officer holding 7,117 shares directly. - Stock Titan
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? - Zacks Investment Research
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity to Hold Earnings Call on November 3, 2026 - Carroll County Mirror-Democrat
Revvity to Hold Earnings Call on November 3, 2026 - Business Wire
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
An officer proposes selling 84 Revvity (NYSE: RVTY) shares valued at $13.1K. - Stock Titan
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.
Cloud Fails To Upend Revvity's $4.5M Fee, Contract Win - Law360
Revvity Inc. stock outperforms competitors on strong trading day - marketwatch.com
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Yahoo Finance
Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings? - TradingView
PKI4882935 Bond Profile: Coupon and Redemption - TradingView
RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection - Yahoo Finance
Full Transcript: Revvity Q2 2026 Earnings Call - Benzinga
Revvity Inc (RVTY) Shares Surge 6.0% -- What GF Score of 78 Tells Investors - GuruFocus
Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years - Benzinga
Revvity shares rise as analyst target hike adds to momentum from deal and guidance - Quiver Quantitative
Revvity Inc. stock outperforms competitors on strong trading day - marketwatch.com
Revvity Inc stock hits 52-week high at 149.72 USD - Investing.com
Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test - finance.yahoo.com
Revvity, Inc. Launches GSP® T1D 3plex Kit For Early Detection Of Type 1 Diabetes - marketscreener.com
RVTY Looks 20.9% Overvalued on GF Value™ as Insider Selling Pers - GuruFocus
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Revvity Inc Azioni (RVTY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gonzales Anita | Officer |
Oct 01 '26 |
Proposed Sale |
155.48 |
84 |
13,060 |
0 |
| Krakowiak Maxwell | Officer |
Sep 21 '26 |
Proposed Sale |
144.53 |
1,631 |
235,728 |
0 |
| Krakowiak Maxwell | Please See Remarks |
Sep 21 '26 |
Sale |
144.53 |
1,631 |
235,728 |
14,781 |
| Vohra Tajinder S | Please See Remarks |
Sep 16 '26 |
Sale |
140.88 |
7,330 |
1,032,650 |
6,635 |
| Vohra Tajinder S | Officer |
Sep 16 '26 |
Proposed Sale |
140.88 |
7,330 |
1,032,650 |
0 |
| Gonzales Anita | Officer |
Jul 20 '26 |
Proposed Sale |
109.48 |
85 |
9,306 |
0 |
| Gonzales Anita | Vice President and CAO |
Jul 20 '26 |
Sale |
109.48 |
85 |
9,306 |
7,201 |
| Gonzales Anita | Officer |
Apr 20 '26 |
Proposed Sale |
92.80 |
80 |
7,424 |
0 |
| Gonzales Anita | Vice President and CAO |
Apr 20 '26 |
Sale |
92.80 |
80 |
7,424 |
7,319 |
| Victor Miriame | Please See Remarks |
Feb 24 '26 |
Option Exercise |
95.74 |
1,862 |
178,268 |
19,984 |
1.31%
2.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):